Literature DB >> 10440628

Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice.

K C Farmer1.   

Abstract

Researchers and clinicians have used numerous methods in their attempts to adequately assess patient compliance (adherence) with medication regimens and to identify noncompliant patients. Large variations have been reported in the extent of noncompliance in individual patients and large populations. In addition, nonadherence has often been poorly defined. Direct measures of adherence include drug assays of blood or urine, use of drug markers with the target medication, and direct observation of the patient receiving the medication. Indirect measures of adherence imply that the medication has been used by the patient; these measures include various forms of self-reporting by the patient, medication measurement (pill count), use of electronic monitoring devices, and review of prescription records and claims. Compliance measures should be assessed on the basis of their validity (sensitivity and specificity or statistical correlation) and the reference standard used. Many early studies used pill counts as a reference standard, but electronic monitoring devices such as the Medication Event Monitoring System have replaced pill counts as the reference standard. The choice of a method for measuring adherence to a medication regimen should be based on the usefulness and reliability of the method in light of the researcher's or clinician's goals. Specific methods may be more applicable to certain situations, depending on the type of adherence being assessed, the precision required, and the intended application of the results.

Entities:  

Mesh:

Year:  1999        PMID: 10440628     DOI: 10.1016/S0149-2918(99)80026-5

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  242 in total

1.  Treating psoriatic arthritis to target: discordance between physicians and patients' assessment, non-adherence, and restricted access to drugs precluded therapy escalation in a real-world cohort.

Authors:  Manoela Fantinel Ferreira; Charles Lubianca Kohem; Ricardo Machado Xavier; Everton Abegg; Otavio Silveira Martins; Marcus Barg Resmini; Ariele Lima de Mello; Franciele de Almeida Menegat; Vanessa Hax; Andrese Aline Gasparin; Claiton Viegas Brenol; Nicole Pamplona Bueno de Andrade; Daniela Viecceli; João Carlos Tavares Brenol; Penélope Esther Palominos
Journal:  Clin Rheumatol       Date:  2018-12-03       Impact factor: 2.980

Review 2.  Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices.

Authors:  Lizheng Shi; Jinan Liu; Yordanka Koleva; Vivian Fonseca; Anupama Kalsekar; Manjiri Pawaskar
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

3.  Methodological issues in the assessment of diabetes treatment adherence.

Authors:  Jeffrey S Gonzalez; Havah E Schneider
Journal:  Curr Diab Rep       Date:  2011-12       Impact factor: 4.810

Review 4.  Modeling and simulation of adherence: approaches and applications in therapeutics.

Authors:  Leslie A Kenna; Line Labbé; Jeffrey S Barrett; Marc Pfister
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

5.  Factors associated with adherence to drug therapy: a population-based study.

Authors:  Annika Bardel; Mari-Ann Wallander; Kurt Svärdsudd
Journal:  Eur J Clin Pharmacol       Date:  2007-01-09       Impact factor: 2.953

6.  Measures and predictors of varenicline adherence in the treatment of nicotine dependence.

Authors:  Annie R Peng; Mark Morales; E Paul Wileyto; Larry W Hawk; Paul Cinciripini; Tony P George; Neal L Benowitz; Nicole L Nollen; Caryn Lerman; Rachel F Tyndale; Robert Schnoll
Journal:  Addict Behav       Date:  2017-07-12       Impact factor: 3.913

7.  Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women.

Authors:  V Rabenda; R Mertens; V Fabri; J Vanoverloop; F Sumkay; C Vannecke; A Deswaef; G A Verpooten; J Y Reginster
Journal:  Osteoporos Int       Date:  2008-06       Impact factor: 4.507

8.  Medication adherence and older renal transplant patients' perceptions of electronic medication monitoring.

Authors:  Cynthia L Russell; Sarah Owens; Karen Q Hamburger; Denise A Thompson; Rebecca R Leach; Muammer Cetingok; Donna Hathaway; Vicki S Conn; Catherine Ashbaugh; Leanne Peace; Richard Madsen; Rebecca P Winsett; Mark R Wakefield
Journal:  J Gerontol Nurs       Date:  2009-10-09       Impact factor: 1.254

9.  Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901.

Authors:  Vanessa B Sheppard; Leigh Anne Faul; George Luta; Jonathan D Clapp; Rachel L Yung; Judy Huei-Yu Wang; Gretchen Kimmick; Claudine Isaacs; Michelle Tallarico; William T Barry; Brandelyn N Pitcher; Clifford Hudis; Eric P Winer; Harvey J Cohen; Hyman B Muss; Arti Hurria; Jeanne S Mandelblatt
Journal:  J Clin Oncol       Date:  2014-06-16       Impact factor: 44.544

10.  Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with heart failure.

Authors:  Jia-Rong Wu; Debra K Moser; Misook L Chung; Terry A Lennie
Journal:  J Card Fail       Date:  2008-04       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.